S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
Clinical trial NCT05101070 · RECRUITING
Trial details
- NCT number
- NCT05101070
- Sponsor
- Shionogi
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2028-05-31
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.